Friday, 12 August 2022

 

 

LATEST NEWS Sporting legacy of Hockey legend Balbir Singh Senior will continue to inspire the generations to come : Meet Hayer GoM Directs To Procure 3.33 Lakh More Doses Of Goat Pox Vaccine To Prevent Lumpy Skin Disease Coka 2.0 Review: Vijay Deverakonda & Ananya Panday’s Burn The Dance Floor With Their New Dance Number As a child, I wanted to be a part of Indian Army : Aditya Narayan 'House of the Dragon' is complex Shakespearean family drama, reveal show makers IANS Review: 'Viruman': An engrossing family entertainer Mahela Jayawardena praises Prabath Jayasuriya, expects spinner to do well for Sri Lanka going forward India need to decide between Rishabh Pant, Dinesh Karthik : Saba Karim Maniesh Paul says hosting 'Jhalak Dikhhla Jaa 10' is like a homecoming Amit Sadh's short film 'Ghuspaith - Beyond Borders' honours photo-journalists Biogas plant commissioned in Punjab uses paddy straw : Aman Arora Google fined $40 mn for misleading users on Android location tracking 'Sikhya-te- Sehat' project to begin from 25 villages of Anandpur Sahib constituency AAP MP Raghav Chadha presents report card on performance during the monsoon session to people Gudti: New Song Of Laung Laachi 2 Is Set To Be Added To Your Romance Playlist CGC Landran commences celebrations to mark India’s 75th Independence Day Adaa Khan, Bishwajit Ghosh collaborate for single 'Baariish Ke Mausam' 49% Indian startups now from tier 2, 3 cities : Dr Jitendra Singh Headless body of young woman found in drain in UP district Beyond 'Thor', 'Lightyear', Malaysia firm on banning films with 'LGBT elements' Anya Singh's 'dream' of working with Zoya Akhtar, Reema Kagti has 'come true'

 

ViroVax's adjuvant to enhance response to Bharat Biotech's Covaxin

Web Admin

Web Admin

5 Dariya News

Hyderabad , 05 Oct 2020

Leading pharmaceutical company Bharat Biotech will use Kansas-based ViroVax's adjuvant Alhydroxiquim-II to boost the immune response to its coronavirus vaccine Covaxin.Covaxin is an inactivated vaccine derived from a strain of SARS-CoV-2 virus, isolated at the National Institute of Virology (NIV), Pune.The inactivated virus is formulated with ViroVax's adjuvant to produce the vaccine candidate, under a licensing agreement.Currently, Bharat Biotech is conducting Phase II clinical trials with Covaxin, approved by the Drugs Controller General of India (DGCI).Explaining the need for adjuvants, components which enhance the effectiveness of medical treatment, Bharat Biotech Chairman and MD Krishna Ella said adjuvants induce greater antibody responses to vaccine antigens, resulting in long-term protection against pathogens."Adjuvants also enhance the sustainability of the global vaccine supply on account of their antigen-sparing effect. Our partnership with ViroVax resonates with Bharat Biotech's relentless efforts towards developing safe and effective vaccines coupled with long-term immunity," said Ella.

According to Ella, aluminium hydroxide adjuvant, widely used in the development of SARS-CoV-2 vaccines, is known to induce Th2-based response, which is important for the eradication of extracellular parasites and bacterial infection."The Th2-based response has a theoretical risk of vaccine associated enhanced respiratory diseases (VAERD or ADE). We have used Imidazoquinoline class of adjuvants (TLR7/8 agonists), which are known to induce Th1-based response which further reduces the risk of ADE (Anti-Body Dependent Enhancement)," he said .He said in Bharat Biotech's preclinical studies and animal challenge models on Syrian Hamster and Rhesus Macaques, Covaxin induced Th1-response due to the use of Algel-IMDG as an adjuvant.Meanwhile, Sunil David from ViroVax said the Kansas company is delighted to partner with Bharat Biotech, a collaboration facilitated by the National Institute of Health.

 

Tags: Coronavirus , COVID 19 , Novel Coronavirus , India Fights Corona , Fight Against Corona , Corona Virus Updates , Social Distancing , Coronavirus Epidemic , Coronavirus Pandemic , Corona virus threat , Corona Outbreak , Covid-19 pandemic , Hyderabad , Drugs Controller General of India , DGCI , National Institute of Virology , NIV , Pune , Bharat Biotech

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2022 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD